Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1

Interventions

Cyclophosphamide 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 8Cyclosporine 8Mycophenolic Acid 6Busulfan 6Filgrastim 5Antilymphocyte Serum 5Radiotherapy 4Psychiatric Rehabilitation 4Methotrexate 4fludarabine 3Whole-Body Irradiation 3Tacrolimus 3Melphalan 3Flow Cytometry 3Cord Blood Stem Cell Transplantation 3Aprepitant 3thymoglobulin 2Therapeutics 2Ondansetron 2Methylprednisolone 2Dexamethasone 2Calcium Dobesilate 2Analgesia 2sargramostim 1merphos 1dexamethasone acetate 1dexamethasone 21-phosphate 1Voriconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Primary Myelofibrosis × Mutation × Clear all
NCT06923670 2025-05-15

Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Not yet recruiting
496 enrolled
Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡